XML 35 R26.htm IDEA: XBRL DOCUMENT v3.20.1
EARNINGS (LOSS) PER SHARE (Tables)
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Schedule of earnings per share, basic and diluted
A reconciliation of the numerators and denominators of the basic and diluted earnings (loss) per share calculations for the three months ended March 31, 2020 and 2019 were as follows:

 
 
Three Months Ended March 31,
(a) 
 
2020
 
2019
Earnings (loss) per share ("EPS"):
 
 

 
 

EPS - basic and diluted:
 
 
 
 
Loss per share from continuing operations
 
$
(0.17
)
 
$
(0.54
)
Loss per share from discontinued operations
 
—

 
(0.04
)
Loss per share
 
$
(0.17
)
 
$
(0.58
)
EPS numerator - basic and diluted:
 
 
 
 
Loss from continuing operations
 
$
(511
)
 
$
(1,771
)
Loss from discontinued operations
 
—

 
(131
)
Net loss
 
$
(511
)
 
$
(1,902
)
EPS denominator (in thousands):
 
 

 
 
Weighted average common stock outstanding - basic
 
3,065

 
3,288

Common stock equivalents: stock options and restricted stock units (b)
 
—

 
—

Weighted average number of common stock outstanding - diluted
 
3,065

 
3,288


(a)
Earnings per share and weighted average shares outstanding for all periods presented reflect the Company's 1-for-10 reverse stock split, which was effective June 10, 2019. 

(b)
The diluted weighted average number of shares of common stock outstanding did not differ from the basic weighted average number of shares of common stock outstanding because the effects of any potential common stock equivalents (see Note 6 for further details on outstanding stock options and unvested restricted stock units) were anti-dilutive and therefore not included in the calculation of the denominator of dilutive earnings per share.
Schedule of antidilutive securities excluded from computation of earnings per share
The weighted average number of shares outstanding used in the computation of diluted net income (loss) per share for the three months ended March 31, 2020 and 2019 did not include the effect of the following potentially outstanding shares of common stock because the effect would have been anti-dilutive:
 
 
Three Months Ended March 31,
 
 
2020
 
2019
Unvested restricted stock units
 
35,771

 
49,736

Stock options
 
5,000

 
5,000

Total
 
40,771

 
54,736